期刊文献+

Clinical study of interventional preoperative bronchial artery infusion chemotherapy combined with surgical resection for advanced non-small cell lung cancer

术前支气管动脉灌注化疗在肺癌手术中的临床研究(英文)
下载PDF
导出
摘要 Objective: How to improve the postoperative 5-year survival rate for lung cancer and to give more patients a chance of surgery have become research hotspots. The aim of this research is to evaluate the clinical and pathohistological responses and effects of preoperative bronchial artery infusion (BAI) chemotherapy in patients with locally advanced (stage Ⅲ) non-small cell lung cancer (NSCLC). Methods: A total of 92 patients with locally advanced NSCLC were randomly divided into two groups. BAI group received BAI chemotherapy for 2 cycles before surgical resection. Surgery group received operation only. The complete resection rate and clinical response were compared between the two groups. Results: In the BAI group, the clinical response rate and the pathohistological response rate were 68.3% and 51.3%, respectively. The complete resection rate in the BAI group was 89.7%, which was significantly higher than that in the surgery group (72.5%) (P 〈 0.05). The 1- and 2-year survival rate was 100.0% and 80.6% in the BAI group, and 94.1% and 60.0% in the surgery group. Conclusion: BAI neoadjuvant chemotherapy is safe and effective, which has a good clinical and pathohistological response. It might increase the complete resection rate of the tumor and improve the long term survival rate of stage Ⅲ NSCLC patients.
出处 《The Chinese-German Journal of Clinical Oncology》 CAS 2007年第6期524-527,共4页 中德临床肿瘤学杂志(英文版)
基金 Supported by a grant from the Foundation of Science and Technology Dalian (No. 20039907).
关键词 non-small cell lung cancer neoadjuvant chemotherapy bronchial artery infusion SURGERY 支气管 动脉 化学疗法 肺癌
  • 相关文献

参考文献4

二级参考文献32

共引文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部